Related Experiment Video
Updated: Oct 15, 2025

13:22
Genetic Screen for Identification of Multicopy Suppressors in Schizosaccharomyces pombe
Published on: September 13, 2022
2.0K
A Screening Method to Identify Essential Yeast Genes for Responses Towards Spermine
Mustapha Aouida1, Dindial Ramotar2
1Division of Biological and Biomedical Sciences, College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar. maouida@hbku.edu.qa.
Methods in Molecular Biology (Clifton, N.J.)
|October 28, 2021
Summary
Researchers used the yeast DAmP mutant collection to find essential genes involved in polyamine resistance. This method efficiently screens genes for drug resistance and sensitivity.
Area of Science:
- Yeast genetics
- Molecular biology
- Drug discovery
Background:
- Polyamines are essential molecules involved in various cellular processes.
- Understanding polyamine resistance mechanisms is crucial for developing new therapeutic strategies.
- The yeast DAmP mutant collection offers a powerful tool for functional genomics studies.
Purpose of the Study:
- To identify essential genes conferring polyamine resistance in yeast.
- To establish a robust methodology for drug screening using the DAmP mutant collection.
- To demonstrate the broad applicability of this screening approach for various compounds.
Main Methods:
- Utilized the yeast DAmP (Deletion with Amplification of the remaining promoter) mutant collection.
- Screened mutants for altered sensitivity or resistance to polyamines.
- Detailed the methodology for gene identification and validation.
Main Results:
- Successfully identified several essential genes implicated in polyamine resistance.
- Demonstrated the efficiency and scalability of the DAmP mutant screening approach.
- Validated the methodology for screening both toxic and nontoxic compounds.
Conclusions:
- The yeast DAmP mutant collection is a valuable resource for identifying genes involved in drug resistance.
- The described methodology provides a versatile platform for high-throughput drug screening.
- This approach can accelerate the discovery of novel therapeutic targets and drug candidates.

